Microbot Medical Inc
Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination f… Read more
Microbot Medical Inc (MBOT) - Net Assets
Latest net assets as of September 2025: $78.22 Million USD
Based on the latest financial reports, Microbot Medical Inc (MBOT) has net assets worth $78.22 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($81.76 Million) and total liabilities ($3.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $78.22 Million |
| % of Total Assets | 95.68% |
| Annual Growth Rate | -4.27% |
| 5-Year Change | -85.48% |
| 10-Year Change | N/A |
| Growth Volatility | 416.68 |
Microbot Medical Inc - Net Assets Trend (1991–2024)
This chart illustrates how Microbot Medical Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Microbot Medical Inc (1991–2024)
The table below shows the annual net assets of Microbot Medical Inc from 1991 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $3.53 Million | -21.57% |
| 2023-12-31 | $4.50 Million | -38.25% |
| 2022-12-31 | $7.29 Million | -49.32% |
| 2021-12-31 | $14.38 Million | -40.84% |
| 2020-12-31 | $24.31 Million | -22.93% |
| 2019-12-31 | $31.54 Million | +2271.43% |
| 2018-12-31 | $1.33 Million | -86.65% |
| 2017-12-31 | $9.96 Million | +487.50% |
| 2016-12-31 | $1.70 Million | +607.78% |
| 2015-12-31 | $-334.00K | -105.69% |
| 2014-12-31 | $5.87 Million | -60.74% |
| 2013-12-31 | $14.95 Million | +6.93% |
| 2012-12-31 | $13.98 Million | +30.39% |
| 2011-12-31 | $10.73 Million | -30.72% |
| 2010-12-31 | $15.48 Million | -49.24% |
| 2009-12-31 | $30.50 Million | +39.83% |
| 2008-12-31 | $21.81 Million | -38.06% |
| 2007-12-31 | $35.21 Million | -35.24% |
| 2006-12-31 | $54.38 Million | +67.95% |
| 2005-12-31 | $32.38 Million | -12.38% |
| 2004-12-31 | $36.95 Million | +237.02% |
| 2003-12-31 | $10.96 Million | +189.46% |
| 2002-12-31 | $3.79 Million | -71.32% |
| 2001-12-31 | $13.21 Million | -42.53% |
| 2000-12-31 | $22.98 Million | +555.43% |
| 1999-12-31 | $3.51 Million | -80.41% |
| 1998-12-31 | $17.90 Million | -38.06% |
| 1997-12-31 | $28.90 Million | -16.71% |
| 1996-12-31 | $34.70 Million | -23.57% |
| 1995-12-31 | $45.40 Million | +100.88% |
| 1994-12-31 | $22.60 Million | -34.49% |
| 1993-12-31 | $34.50 Million | +18.15% |
| 1992-12-31 | $29.20 Million | +95.97% |
| 1991-12-31 | $14.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Microbot Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7964400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $195.00K | 5.52% |
| Other Components | $94.28 Million | 2670.79% |
| Total Equity | $3.53 Million | 100.00% |
Microbot Medical Inc Competitors by Market Cap
The table below lists competitors of Microbot Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Huang Hsiang Construction Corp
TW:2545
|
$145.77 Million |
|
China Dongxiang (Group) Co. Ltd
F:4C1
|
$145.79 Million |
|
Orsero S.p.A.
LSE:0YCG
|
$145.81 Million |
|
Datalex plc
PINK:DLEXY
|
$145.82 Million |
|
Halk Gayrimenkul Yatirim Ortakligi AS
IS:HLGYO
|
$145.70 Million |
|
British American Tobacco Malaysia Bhd
KLSE:4162
|
$145.66 Million |
|
PRIMA MARINE PCL-NVDR
BK:PRM-R
|
$145.66 Million |
|
PNGJL
NSE:PNGJL
|
$145.62 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Microbot Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,501,000 to 3,530,000, a change of -971,000 (-21.6%).
- Net loss of 11,443,000 reduced equity.
- New share issuances of 7,936,000 increased equity.
- Other factors increased equity by 2,536,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.44 Million | -324.16% |
| Share Issuances | $7.94 Million | +224.82% |
| Other Changes | $2.54 Million | +71.84% |
| Total Change | $- | -21.57% |
Book Value vs Market Value Analysis
This analysis compares Microbot Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.23x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.00x to 12.23x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1991-12-31 | $38303.34 | $2.76 | x |
| 1992-12-31 | $60455.49 | $2.76 | x |
| 1993-12-31 | $53405.57 | $2.76 | x |
| 1994-12-31 | $33284.24 | $2.76 | x |
| 1995-12-31 | $48504.27 | $2.76 | x |
| 1996-12-31 | $36033.23 | $2.76 | x |
| 1997-12-31 | $33816.43 | $2.76 | x |
| 1998-12-31 | $15854.74 | $2.76 | x |
| 1999-12-31 | $3030.60 | $2.76 | x |
| 2000-12-31 | $18563.83 | $2.76 | x |
| 2001-12-31 | $9121.41 | $2.76 | x |
| 2002-12-31 | $2445.17 | $2.76 | x |
| 2003-12-31 | $5537.15 | $2.76 | x |
| 2004-12-31 | $12067.13 | $2.76 | x |
| 2005-12-31 | $8242.26 | $2.76 | x |
| 2006-12-31 | $11808.04 | $2.76 | x |
| 2007-12-31 | $7151.08 | $2.76 | x |
| 2008-12-31 | $4271.25 | $2.76 | x |
| 2009-12-31 | $4658.58 | $2.76 | x |
| 2010-12-31 | $2033.98 | $2.76 | x |
| 2011-12-31 | $1224.75 | $2.76 | x |
| 2012-12-31 | $786.01 | $2.76 | x |
| 2013-12-31 | $557.92 | $2.76 | x |
| 2014-12-31 | $154.37 | $2.76 | x |
| 2015-12-31 | $-4.56 | $2.76 | x |
| 2016-12-31 | $1.78 | $2.76 | x |
| 2017-12-31 | $1.12 | $2.76 | x |
| 2018-12-31 | $0.15 | $2.76 | x |
| 2019-12-31 | $7.39 | $2.76 | x |
| 2020-12-31 | $3.42 | $2.76 | x |
| 2021-12-31 | $2.02 | $2.76 | x |
| 2022-12-31 | $1.00 | $2.76 | x |
| 2023-12-31 | $0.44 | $2.76 | x |
| 2024-12-31 | $0.23 | $2.76 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Microbot Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -324.16%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.71x
- Recent ROE (-324.16%) is below the historical average (-148.75%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1991 | -42.95% | -1280.00% | 0.03x | 1.16x | $-7.89 Million |
| 1992 | -34.25% | -714.29% | 0.04x | 1.21x | $-12.92 Million |
| 1993 | -36.23% | -416.67% | 0.07x | 1.19x | $-15.95 Million |
| 1994 | -73.01% | -1269.23% | 0.04x | 1.42x | $-18.76 Million |
| 1995 | -19.60% | -75.42% | 0.21x | 1.25x | $-13.44 Million |
| 1996 | -39.77% | -194.37% | 0.12x | 1.68x | $-17.27 Million |
| 1997 | -51.71% | -170.75% | 0.24x | 1.27x | $-21.60 Million |
| 1998 | -70.39% | -143.13% | 0.27x | 1.84x | $-14.39 Million |
| 1999 | -448.01% | -312.80% | 0.32x | 4.50x | $-16.06 Million |
| 2000 | -49.35% | -15263.80% | 0.00x | 1.30x | $-13.64 Million |
| 2001 | -26.09% | -427.95% | 0.04x | 1.58x | $-4.77 Million |
| 2002 | -273.66% | -2495.32% | 0.04x | 2.99x | $-10.74 Million |
| 2003 | -112.11% | -4495.12% | 0.01x | 1.80x | $-13.39 Million |
| 2004 | -41.49% | -10869.72% | 0.00x | 1.29x | $-19.02 Million |
| 2005 | -36.26% | -5700.44% | 0.00x | 1.38x | $-14.98 Million |
| 2006 | -34.85% | -20407.11% | 0.00x | 1.23x | $-24.39 Million |
| 2007 | -71.06% | -44115.16% | 0.00x | 1.37x | $-28.54 Million |
| 2008 | -133.37% | -12552.11% | 0.01x | 1.89x | $-31.27 Million |
| 2009 | -88.62% | -2722.01% | 0.02x | 1.68x | $-30.08 Million |
| 2010 | -163.07% | -1769.03% | 0.05x | 1.98x | $-26.79 Million |
| 2011 | -198.87% | -1746.85% | 0.05x | 2.35x | $-22.40 Million |
| 2012 | -203.73% | -2082.68% | 0.05x | 2.16x | $-29.89 Million |
| 2013 | -176.80% | -2197.77% | 0.03x | 2.78x | $-27.93 Million |
| 2014 | -557.67% | -3235.28% | 0.03x | 5.52x | $-33.33 Million |
| 2015 | 0.00% | -31123.93% | 0.01x | 0.00x | $-36.38 Million |
| 2016 | -569.75% | 0.00% | 0.00x | 1.99x | $-9.83 Million |
| 2017 | -76.16% | 0.00% | 0.00x | 1.11x | $-8.59 Million |
| 2018 | -545.86% | 0.00% | 0.00x | 4.58x | $-7.39 Million |
| 2019 | -22.98% | 0.00% | 0.00x | 1.18x | $-10.40 Million |
| 2020 | -37.72% | 0.00% | 0.00x | 1.08x | $-11.60 Million |
| 2021 | -78.67% | 0.00% | 0.00x | 1.17x | $-12.75 Million |
| 2022 | -180.66% | 0.00% | 0.00x | 1.31x | $-13.90 Million |
| 2023 | -238.61% | 0.00% | 0.00x | 1.85x | $-11.19 Million |
| 2024 | -324.16% | 0.00% | 0.00x | 1.71x | $-11.80 Million |
Industry Comparison
This section compares Microbot Medical Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Microbot Medical Inc (MBOT) | $78.22 Million | -42.95% | 0.05x | $145.73 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |